PMID: 2982302Mar 1, 1985Paper

Long-term estrogen replacement therapy prevents bone loss and fractures

Annals of Internal Medicine
B EttingerC E Cann

Abstract

Although several case-control studies have shown an inverse association between postmenopausal estrogen use and fractures, quantitation of fracture incidence has been lacking. To quantify the degree to which estrogen replacement therapy prevents postmenopausal osteoporosis, a retrospective study was done comparing the occurrence of fractures in 245 long-term estrogen users and 245 case-matched controls, followed for an average of 17.6 years. Quantitative bone mineral assessments were obtained from 18 women using estrogen replacement therapy and their controls (average age, 73 years). Osteoporotic fracture incidence in estrogen users was 50% as great as in the controls (p less than 0.01). Estrogen users showed significantly greater bone mineral: 54.2% greater spinal mineral (p less than 0.0002), 19.4% greater forearm mineral (p less than 0.0005), and 15.6% greater metacarpal cortical thickness (p less than 0.005). Long-term estrogen replacement therapy confers significant protection against bone loss and fracture.

Citations

Jun 16, 2001·American Journal of Human Biology : the Official Journal of the Human Biology Council·Y Beyene, M C Martin
Jun 1, 1993·Arthritis and Rheumatism·D J CookE F Juniper
Dec 1, 1996·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·M T Hannan
Apr 1, 1992·Calcified Tissue International·R Pacifici
Nov 1, 1993·Breast Cancer Research and Treatment·R Vassilopoulou-Sellin
Jan 1, 1993·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·R LindsayJ Nieves
Jan 1, 1997·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J M Cardona, E Pastor
Jan 1, 1997·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J M PouillesD Kuntz
Jan 1, 1993·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·D M BlackS R Cummings
Nov 1, 1992·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M R StegmanR P Heaney
Jan 1, 1993·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·R Lindsay
Mar 1, 1994·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·D ThiébaudC Gobelet
Jan 1, 1994·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P J MeunierF Duboeuf
Jan 1, 1995·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P MaximG M Spitalny
Jul 1, 1992·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·A P Clark, J A Schuttinga
Sep 1, 1992·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·T D SpectorA J Silman
Jun 1, 1991·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P D MillerL Kowalski
Dec 1, 1993·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·R LehmannB Allolio
Jan 1, 1996·Breast Cancer Research and Treatment·J D SibongaR T Turner
Nov 1, 1994·Cancer Causes & Control : CCC·I PerssonJ F Fraumeni
Oct 1, 1990·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·C Christiansen, R Lindsay
Jun 1, 1989·Clinical Rheumatology·R Pérez CanoM Garrido
Sep 1, 1995·Clinical Rheumatology·S RozenbergJ Vandromme
Aug 1, 1987·Calcified Tissue International·L J MeltonB L Riggs
Feb 1, 1990·Calcified Tissue International·D B Kimmel, T J Wronski
Apr 1, 1991·Calcified Tissue International·L V Avioli, R P Heaney
Jan 1, 1991·Calcified Tissue International·L V Avioli
Jul 1, 1994·Journal of General Internal Medicine·W W LivingstonJ L Zazzali
Jan 1, 1997·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·C Christiansen
Jan 1, 1997·Calcified Tissue International·D Agnusdei, L Bufalino
Jan 1, 1997·Calcified Tissue International·J Y ReginsterC Roux
May 13, 2008·Journal of Bone and Mineral Metabolism·Chunli SongGengting Dang
Jun 6, 2009·Journal of Bone and Mineral Metabolism·Mitsuyoshi TsujiEiji Takeda
Sep 6, 2012·Journal of Bone and Mineral Metabolism·Naoko HonmaHideki Ito
Apr 3, 2013·Breast Cancer Research and Treatment·Adetunji T Toriola, Graham A Colditz
Jun 28, 2002·Comprehensive Therapy·Daphne J TheodorouDavid J Sartoris
Oct 1, 1989·American Journal of Obstetrics and Gynecology·R B MazessW Utian
Feb 1, 1996·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·S Gupta, J Rymer
Apr 21, 1992·European Journal of Obstetrics, Gynecology, and Reproductive Biology·C Castelo-BrancoJ González-Merlo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
R A EvansS Kos
© 2021 Meta ULC. All rights reserved